cas 2092707-38-3|| where to buy 2-oxaspiro[3.5]nonan-7-ol

Nom du produit:2-oxaspiro[3.5]nonan-7-ol

IUPAC Name:2-oxaspiro[3.5]nonan-7-ol

Unité d'emballage	Stock disponible	Prix($)
CM855572-100mg	in stock	ŹǪ
CM855572-250mg	in stock	Ǚȃƿ
CM855572-1g	in stock	ľŗǪ
CM855572-5g	in stock	Ǚƥȃƥ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 2092707-38-3 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:2092707-38-3; Formule moléculaire:C8H14O2; Point de fusion:-; Code SMILES:OC1CCC2(COC2)CC1; Densité:

: Numéro de catalogue:CM855572; Poids moléculaire:142.2; Point d'ébullition:; N° Mdl:; Stockage:

: Cyclohexanes; Cyclohexane is an organic compound with a chemical formula C6H12. It is a colorless liquid with a pungent odor, insoluble in water, and soluble in most organic solvents such as ethanol, ether, benzene, and acetone. Cyclohexyl fragments are a common structure in both natural and synthetic drugs. It can be used as both core structure and part of achiral side chain.

: Oxetanes; Oxygen heterocycles are one of the most common heterocycles in drugs and natural products. Oxetene has high polarity and is also a good acceptor for hydrogen bond, which contributes to the metabolism and chemical stability of its host molecules. When substituted for commonly used functional groups such as gem dimethyl or carbonyl, oxetane units can induce profound changes in water solubility, lipophilicity, metabolic stability and conformational preference. Four of the FDA-approved drugs contain oxetenes: Orlistat, Paclitaxel, and two of its derivatives, Docetaxel and Cabazitaxel. Currently, oxetane-containing building blocks are flourishing in medicinal chemistry and drug discovery.